Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem
Name | Oktreotid Teva 20 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-487108635 |
Active Substance | oktreotidacetat |
Composition | svaka bočica sadrži oktreotidacetat što odgovara 20 mg oktreotida |
Pharmaceutical Form | prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
Manufacturer | Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska Pharmathen International S.A., Rodopi, Grčka |
Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
Marketing Authorisation Date | 12.04.2024 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/23-02/128 |
Registration Number | 381-12-01/171-24-03 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | H01CB02 |
Medicinal product marketed in the Croatia | Nestašica |
SmPC | download |
PL | download |
Public Assessment Report | download |